Aridis Pharmaceuticals Inc
(ARDS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 3,091 | 1,535 | 1,000 | 1,022 | 2,757 |
| Gross Profit | 3,091 | 1,535 | 1,000 | 1,022 | 2,757 |
| Operating Expenses | 33,084 | 44,246 | 23,401 | 30,109 | 26,874 |
| Operating Income | -29,993 | -42,711 | -22,401 | -29,087 | -24,117 |
| Other Income | -378 | 518 | 68 | -594 | 2,012 |
| Pre-tax Income | -30,371 | -42,193 | -22,333 | -29,681 | -22,105 |
| Net Income Continuous | -30,371 | -42,193 | -22,333 | -29,681 | -22,105 |
| Net Income | $-30,371 | $-42,193 | $-22,333 | $-29,681 | $-22,105 |
| EPS Basic Total Ops | -1.62 | -3.77 | -2.44 | -3.51 | -7.45 |
| EPS Basic Continuous Ops | -1.62 | -3.43 | -2.44 | -3.51 | -7.03 |
| EPS Diluted Total Ops | -1.62 | -3.77 | -2.44 | -3.51 | -7.45 |
| EPS Diluted Continuous Ops | -1.62 | -3.43 | -2.44 | -3.51 | -7.03 |
| EPS Diluted Before Non-Recurring Items | -1.62 | -3.85 | -2.44 | -3.51 | -7.01 |
| EBITDA(a) | $-29,506 | $-42,276 | $-22,064 | $-28,749 | $-23,834 |